) has deployed a new mobility and communications solution named
CareAware Connect for clinicians using smart phone devices. This
positive news should further boost investor confidence on the
stock, which has already risen 4% since Oct 1.
ATHENAHEALTH IN (ATHN): Free Stock Analysis
CARDINAL HEALTH (CAH): Free Stock Analysis
CERNER CORP (CERN): Free Stock Analysis
QUALITY SYS (QSII): Free Stock Analysis
To read this article on Zacks.com click here.
CareAware Connect is a clinical mobility solution, which allows
clinicians to communicate as well as access electronic health
record (EHR) data and alerts on their smart phones. It has been
initially designed to run on the Apple iPhone. Cerner has
successfully set up this new tool for clinicians at Fisher-Titus
Medical Center in Norwalk, Ohio, and the NCH Healthcare System in
Management asserts that CareAware Connect is a fast, easy and
smart tool, enabling smooth coordination between medical devices,
health care applications and EHR systems. Some of the special
features of this advanced mobile solution include voice calls
within as well as outside clinical settings, secure messaging
amongst caregivers, and review EHR data and alerts on smarphones.
Cerner plans to further expand CareAware Connect to physicians
and add bar-code enabled workflows in future versions.
Although the new product is expected to accelerate CERN's
top-line growth, we are cognizant of stiff competition in the
underlying market. Recently, Cerner's peer,
) launched a new mobile application (app), "Epocrates Bugs +
Drugs," which combines cloud-based clinical data with a
user-friendly mobile interface.
) and ITelagen has launched NextGenAnywhere, a technology that
delivers the NextGen Ambulatory EHR to mobile devices. Available
for iPad and Android tablet mobile devices, NextGenAnywhere is
powered by ITelagen's innovative EHRAnywhere platform to enable
physicians the freedom and flexibility to access patient medical
data and applications.
Cerner presently has a Zacks Rank #3 (Hold). While we choose to
remain on the sidelines regarding CERN, medical stock
Cardinal Health, Inc.
) carrying a Zacks Rank #1 (Strong Buy), warrants a look.